search
Front

BiolineRX files prospectus for Nasdaq offering

26 Sep, 2010 9:21
שלח תגובה במיילMira Awad

The drug development company plans raising $40.25 million.

Drug development company BiolineRX Ltd. (TASE:BLRX) has filed a prospectus with the US Securities and Exchange Commission (SEC) for a Nasdaq offering. According to the prospectus, the Jerusalem-based company plans raising $40.25 million "as soon as practicable."

The prospectus reveals that BiolineRX's ticker will be BLRX on Nasdaq, the same as its ticker on the Tel Aviv Stock Exchange (TASE). The lead underwriters for the IPO will be Oppenheimer & Co. and JMP Securities.

BiolineRX stated in the prospectus that $21 million of the funds that it plans raising will be used to finance clinical trials for four of the drugs that it is developing. $5 million will be used for feasibility research for 12 more drugs and $5 million will be allocated management, marketing and sales expenses.

BiolineRX recently signed an out-licensing deal to further its schizophrenia drug with Cypress Bioscience Inc., which earns the Israeli company an initial payment of $30 million.

As of today, Bioline has 11 drugs in its pipeline and has signed two commercialization agreements - for the schizophrenia treatment and a hear treatment. At the same time, nine more treatments are being examined as part of the EDP program for developing early stage materials.

Bioline's share opened 4% higher this morning at NIS 3.60 on the TASE, giving a market cap of NIS 452 million.

Published by Globes, Israel business news - www.globes-online.com - on September 26, 2010

© Copyright of Globes Publisher Itonut (1983) Ltd. 2010

Bezalel Smotrich and Amir Yaron credit: Knesset Spokesperson and Tali Bogdanovsky Retail chains, credit card cos could soon act as banks

Israel's financial regulators have proposed that supermarket chains, credit card companies and investment houses will be able to accept deposits and offer credit.

Nvidia VP Ali Kani credit: Nvidia Nvidia intensifies efforts to compete with Mobileye

"Globes" talks to Nvidia VP and automotive team head Ali Kani about the chipmaker's autonomous vehicle activities and assesses the threat to Mobileye.

Elbit Systems rocket launcher credit: Elbit Systems Elbit Systems wins $130m European rocket order

The order is for the supply of rockets for Elbit's Precise and Universal Launching System (PULS), which has an effective range of up to 300 kilometers.

Fitch ratings agency credit: Shutterstock Fitch reaffirms Israel's A rating with negative outlook

The ratings agency said, "The negative outlook reflects rising public debt, domestic political and governance challenges and uncertain prospects for the conflict in Gaza."

Miri Regev and Yitzhak Rochberger credit: Yediot Ahronot/ Reuven Kapuchinsky and Amit Shabi Ramat Hasharon wants railway station for the Mossad

Ramat Hasharon is pushing for a station in Glilot neat the Mossad headquarters, even though a new station is also planned for Glilot South, 1.6 kilometers away.

Fencing goes up Petah Tikva's Segula neighborhood credit: NTA Work on Metro to begin in Petah Tikva

The first work on the Tel Aviv Metropolitan underground railways system will begin on the M2 line depot in Petah Tikva.

Highcon chairperson Shlomo Nimrodi credit: PR Packaging tech co Highcon winding down

The company, which numbers Benny Landa and JVP among its investors, is laying off most of its workforce, having lost 99.9% of its value since its flotation.

Big banks CEOs credit: Oren Dai, Jonthan Bloom and Israel Hadari Israeli banks unveil NIS 3b customer benefits package

The benefits over two years meet the target set by the Bank of Israel to ease the burden for customers, while the banks are reporting record profits.

Record public company profits credit: Tali Bogdanovsky Profits peak, but reckoning awaits

In what may seem a paradox, profits grew in almost every sector on the Tel Aviv Stock Exchange last year, but the boom was largely fueled by government spending.

Tel Aviv Stock Exchange credit: PR Volumes peak on Tel Aviv Stock Exchange

Greater optimism in Israel and a shift away from US markets have brought trading volumes in Tel Aviv to a historical high, but will the trend be sustained?

Ishay Davidi credit: Cadya Levy FIMI CEO: Foreign investors flocking back to Israel

Ishay Davidi told the Globes "Going Long on Israel" Conference that investors who pulled out of Israel after October 7 have begun returning in large numbers.

Tel Aviv Stock Exchange credit: Shutterstock Tel Aviv stocks: Rebound or long slide?

Statistics show a two-thirds chance of high returns after a steep one-day fall. Yields on Israel government bonds are rising sharply.

Tamar rig credit: PR Sovereign Wealth Fund earned handsome returns in 2024

Israel's Sovereign Wealth Fund, known as the Citizens' Fund, had assets worth about $2 billion at the end of 2024, the Ministry of Finance reports.

Bank of Israel credit: Shutterstock/Alon Adika Bank of Israel slams gov't fiscal policy

Governor Prof. Amir Yaron wrote in the annual report that the government's measures are not enough to ensure a sustained decline in debt-to-GDP ratio.

Minimum wage credit: Tali Bogdanovsky Minimum wage in Israel to rise next week

The monthly minimum wage in Israel will be revised upwards by 6%.

Moody's, Benjamin Netanyahu, Bezalel Smotrich, credit: Shutter stock, Government Spokesperson, Tali Bogdanovsky Moody's: Political risks weigh on Israel's rating

"Israel's sovereign credit profile reflects very high political risks that have weakened economic and fiscal strength."

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018